Virtu Financial’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-25,140
| Closed | -$1.03M | – | 2068 |
|
|
2024
Q2 | $1.03M | Buy |
+25,140
| New | +$1.03M | 0.07% | 289 |
|
|
2024
Q1 | – | Sell |
-5,803
| Closed | -$246K | – | 2309 |
|
|
2023
Q4 | $246K | Buy |
+5,803
| New | +$246K | 0.02% | 703 |
|
|
2023
Q3 | – | Sell |
-14,053
| Closed | -$447K | – | 2070 |
|
|
2023
Q2 | $447K | Buy |
+14,053
| New | +$447K | 0.03% | 436 |
|
|
2021
Q4 | – | Sell |
-8,525
| Closed | -$251K | – | 2282 |
|
|
2021
Q3 | $251K | Buy |
+8,525
| New | +$251K | 0.02% | 801 |
|
|
2021
Q1 | – | Sell |
-15,478
| Closed | -$257K | – | 2138 |
|
|
2020
Q4 | $257K | Buy |
+15,478
| New | +$257K | 0.03% | 721 |
|